How exposure to heavy metals, nanoparticles, and emerging contaminants relates to allergic skin and systemic metal reactions
Official title: Model of diseAses Related to Environmental Exposure to Heavy meTals, nanopaRticles and Emergent Contaminants, Using a dIgital platfOrm of Clinical and Bio-humoral Data: the Way to Susceptibility/RisK BiomArker [MATRIOSKA Study] - The Seed.
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06529913 · Data updated 2026-11-12
This project will test whether adults with allergic contact dermatitis or systemic metal allergies have different levels of heavy metals, nanoparticles, and related blood and urine markers compared with healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 280 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 2 sites (Bologna and 1 other locations) |
| Status | Recruiting |
| Started | January 13, 2025 |
| Main results expected | September 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT06529913 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) with allergic contact dermatitis due to metals or with systemic metal allergic syndrome, as well as healthy adult volunteers able to give written informed consent, are ideal candidates.
✕Probably not a fit
Individuals under 18, pregnant or breastfeeding women, patients with chronic renal failure requiring replacement therapy, those with other systemic metal-related diseases, or people with certain gastrointestinal or other skin diseases are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will recruit three adult groups—patients with systemic metal allergic syndrome, patients with allergic contact dermatitis due to metals, and healthy controls—and collect environmental, biological, and clinical data. investigators will measure serum and urine concentrations of metals and nanoparticles, perform metal patch testing, record within-breath oscillometry parameters, and analyze serum zonulin and protein oxidation products. Environmental sampling and exposure histories will be obtained to link external exposures with biological markers. Results will be compared across the three groups to determine whether exposed patients show distinct biomarker or clinical profiles.
Why it matters
Potential benefit: If successful, this could identify exposure-related biomarkers that improve diagnosis, prevention, and management of metal-related allergic conditions.
How similar studies have gone: Prior research has established links between metal exposure and contact dermatitis, but combining nanoparticle measurements with zonulin and protein oxidation markers is relatively novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult subjects (over 18 years of age). * Subjects suffering from allergic contact dermatitis due to metals. * Subjects with systemic allergic syndrome due to metals. * Adult healthy subjects. * Subjects able to give written informed consent. Exclusion Criteria: * Subjects under the age of 18years. * Pregnant/breastfeeding women. * Subjects suffering from chronic renal failure requiring replacement treatment. * Subjects suffering from other systemic pathologies related to exposure to metals. * Subjects suffering from gastrointestinal diseases such as celiac disease, chronic inflammatory intestinal diseases, tumors, other skin diseases. * Subjects unable to express written informed consent.
Where it's running
-
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy Recruiting -
Università di Bologna
Bologna, Italy Not yet recruiting
Study contacts
- Principal investigator: Angela Rizzi, MD, PhD — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Angela Rizzi, MD, PhD
- Email: angela.rizzi@policlinicogemelli.it
- Phone: +390630154952
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Normal lung and heart function references for healthy US veterans who served in Southwest Asia
This study tests whether healthy veterans aged 24–68 who did not have exposure to airborne hazards have normal lung and heart function values that can serve as reference standards.
-
Barts Children's Environmental Health Clinic
This service will try personal and home pollution monitoring plus tailored exposure-reduction plans for children aged 4–17 with chronic respiratory conditions to see if those steps lower their environmental exposures.
-
Research on lung cancer screening behaviors and outcomes in high-risk individuals in Taiwan
This study looks at how high-risk individuals in Taiwan, like smokers or those with a family history of lung cancer, are getting screened for lung cancer using low-dose CT scans to see how effective these screenings are.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
-
Testing combined H1 and H2 antihistamines for functional dyspepsia
We’re testing whether a combination of an H1 antihistamine and an H2 antihistamine helps people with functional dyspepsia more than a single antihistamine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.